CSF2 and granular corneal dystrophy type II: Immunological blood testing (Figure 6) showed that MC acts as an effective corrector of the inflammatory process in ACD, its use led to a decrease in the level of the main pro-inflammatory cytokines involved in the pathogenesis of ACD: IL-2, TNF-α and GM-CSF.